Cargando…
Medications for opioid use disorder save lives /
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
National Academies Press,
[2019]
|
| Colección: | Consensus study report.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_on1096298025 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 190602s2019 dcuab obt 000 0 eng | ||
| 040 | |a NLM |b eng |e rda |e pn |c NLM |d EBLCP |d CUS |d OCLCF |d N$T |d XFF |d NLM |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d UKAHL |d OCLCQ |d OCLCO |d OCLCA |d K6U |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCL |d TMA |d OCLCL |d OCLCQ | ||
| 016 | 7 | |a 101748697 |2 DNLM | |
| 020 | |a 9780309486514 |q (electronic bk.) | ||
| 020 | |a 0309486513 |q (electronic bk.) | ||
| 020 | |z 9780309486484 | ||
| 020 | |z 0309486483 | ||
| 029 | 0 | |a NLM |b 101748697 | |
| 029 | 1 | |a AU@ |b 000065375988 | |
| 035 | |a (OCoLC)1096298025 | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RC568.O45 | |
| 060 | 0 | 0 | |a 2019 F-954 |
| 060 | 1 | 0 | |a WM 284 |
| 082 | 0 | 4 | |a 615.7/822 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Medications for opioid use disorder save lives / |c Committee on Medication-Assisted Treatment for Opioid Use Disorder ; Alan I. Leshner and Michelle Mancher, editors ; Board on Health Sciences Policy, Health and Medicine Division. |
| 264 | 1 | |a Washington, DC : |b National Academies Press, |c [2019] | |
| 300 | |a 1 online resource (1 PDF file (xviii, 156 pages)) : |b illustrations, maps | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |2 rda | ||
| 347 | |b PDF | ||
| 490 | 1 | |a Consensus study report of the National Academies of Sciences, Engineering, Medicine | |
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already exist--like evidence-based medications--are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed. | |
| 536 | |a This activity was supported by a contract between the National Academy of Sciences and the National Institutes of Health (HHSN263201800029I/HHSN26300005) and the Substance Abuse and Mental Health Services Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. | ||
| 588 | 0 | |a Online resource; title from PDF title page (viewed August 23, 2019). | |
| 505 | 0 | |a Introduction -- The effectiveness of medication-based treatment for opioid use disorder -- Treatment with medications for opioid use disorder in different populations -- Medications for opioid use disorder in various treatment settings -- Barriers to broader use of medications to treat opioid use disorder -- Appendixes | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Opioid abuse |x Treatment |z United States. | |
| 650 | 0 | |a Drug addicts |x Rehabilitation |z United States. | |
| 650 | 0 | |a Opioids |x Overdose |x Treatment |z United States. | |
| 650 | 0 | |a Brain |x Diseases |x Treatment |z United States. | |
| 650 | 0 | |a Opioid abuse |x Prevention |x Government policy. | |
| 650 | 0 | |a Methadone maintenance |z United States. | |
| 650 | 0 | |a Buprenorphine |x Therapeutic use |z United States. | |
| 650 | 0 | |a Naloxone |x Therapeutic use |z United States. | |
| 650 | 0 | |a Naltrexone |x Therapeutic use |z United States. | |
| 650 | 0 | |a Drugs |x Overdose. | |
| 650 | 1 | 2 | |a Opiate Substitution Treatment |
| 650 | 1 | 2 | |a Opioid-Related Disorders |x drug therapy |
| 650 | 2 | 2 | |a Drug Users |
| 650 | 2 | 2 | |a Drug Overdose |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Toxicomanie aux opiacés |x Traitement |z États-Unis. | |
| 650 | 6 | |a Toxicomanes |x Réadaptation |z États-Unis. | |
| 650 | 6 | |a Opioïdes |x Surdosage |x Traitement |z États-Unis. | |
| 650 | 6 | |a Cerveau |x Maladies |x Traitement |z États-Unis. | |
| 650 | 6 | |a Méthadone |x Emploi en thérapeutique |z États-Unis. | |
| 650 | 6 | |a Buprénorphine |x Emploi en thérapeutique |z États-Unis. | |
| 650 | 6 | |a Naloxone |x Emploi en thérapeutique |z États-Unis. | |
| 650 | 6 | |a Naltrexone |x Emploi en thérapeutique |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Surdosage. | |
| 650 | 7 | |a Drugs |x Overdose |2 fast | |
| 650 | 7 | |a Brain |x Diseases |x Treatment |2 fast | |
| 650 | 7 | |a Buprenorphine |x Therapeutic use |2 fast | |
| 650 | 7 | |a Drug addicts |x Rehabilitation |2 fast | |
| 650 | 7 | |a Methadone maintenance |2 fast | |
| 650 | 7 | |a Opioid abuse |x Treatment |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 700 | 1 | |a Mancher, Michelle, |e editor. | |
| 700 | 1 | |a Leshner, Alan I., |d 1944- |e editor. | |
| 710 | 2 | |a National Academies of Sciences, Engineering, and Medicine (U.S.). |b Committee on Medication-Assisted Treatment for Opioid Use Disorder, |e issuing body. | |
| 758 | |i has work: |a Medications for opioid use disorder save lives (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGM8Dv38XBvkwtMrPMr4jd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 830 | 0 | |a Consensus study report. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5774508 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36618616 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL5774508 | ||
| 938 | |a EBSCOhost |b EBSC |n 2186517 | ||
| 994 | |a 92 |b IZTAP | ||